University of Lynchburg chaplain and assistant vice president for belonging Nathan Albert was elected president of the board ...

The drug, vepdegestrant, failed to meaningfully delay cancer progression for all patients enrolled in the study but met its goals for a subset who have a specific genetic mutation ...